Researchers identify four new targets for breast cancer
Four suspects often found at the scene of the crime in cancer are guilty of the initiation and progression of breast cancer in mice that are resistant to the disease, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the June edition of Cancer Cell. "We have a smoking gun" that shows it's no coincidence the three protein receptors and the enzyme that makes them are abnormally expressed in many types of cancer, said Gordon Mills, M.D., Ph.D., professor and chair of M. D. Anderson's Department of Systems Biology and senior author of the paper.
"We've compiled lots of evidence that they are associated with cancer, what's been missing is proof that they could cause cancer," Mills said. "There are no questions left, they should be targeted."
The four are three lysophosphatidic acid (LPA) receptors (LPA1, LPA2, and LPA3) and the LPA-producing enzyme, autotaxin. "Lysophosphatidic acid", Mills said, "is the single most potent known cellular survival factor." LPA binds to a series of G protein-coupled receptors to spark normal cell proliferation, viability, production of growth factors and survival. The Cancer Cell paper shows this powerful network is hijacked to initiate breast cancer and fuel tumor growth, invasion and metastasis.
The team took a strain of mice that is highly resistant to breast cancer and then created four transgenic strains, each strain expressing one of the receptors or autotaxin.
At 24 months, none of the 44 original cancer-resistant mice developed mammary gland cancer. Only one case of inflammation and two cases of a potentially precancerous accumulation of cells known as hyperplasia were noted.
Cancer incidence ranged from 32 percent to 52.8 percent in the four strains of mice with one of the culprit receptors or autotaxin. Invasive and/or metastatic tumors were present to varying degrees, with 45.5 percent of the tumors in the LPA3 strain metastasizing.
A number of drugs are in preclinical development that target the receptors and autotaxin, Mills said. "Now we have transgenic mouse models to test drugs to go forward against these targets."
The four transgenic strains of mice have three unusual characteristics that the team believes make them particularly well-suited as a model of human breast cancer. Unlike most other mouse models, these produce breast cancer that is invasive and metastatic, and some tumors that are estrogen-receptor positive. ER-positive disease is the most common type of breast cancer.
- Erythropoietin counteracts breast cancer treatment with herceptinMon, 15 Nov 2010, 17:05:54 EST
- Researchers identify risk factors for contralateral breast cancerMon, 26 Jan 2009, 0:22:17 EST
- Combination overcomes breast cancer resistance to herceptinSun, 13 Mar 2011, 14:33:16 EDT
- M. D. Anderson study questions true favorability of rare breast cancer typeSat, 12 Dec 2009, 8:37:40 EST
- Study points toward relationship between cancer stem cells and prognosis in primary breast cancerFri, 15 May 2009, 3:09:18 EDT
Articles on the same topic
- NYU Langone Medical Center researchers identify key gene in deadly inflammatory breast cancerSun, 14 Jun 2009, 13:44:09 EDT
- Targeting breast cancer stem cells in miceMon, 1 Jun 2009, 20:22:53 EDT
- U-M researchers link pathway to breast cancer stem cellsMon, 1 Jun 2009, 20:22:51 EDT
- Researchers find breast cancer gene that's blocked by blood pressure drugMon, 1 Jun 2009, 17:24:03 EDT
- Key Gene In Deadly Inflammatory Breast Cancer Identifiedfrom Science DailySun, 14 Jun 2009, 16:28:12 EDT
- Researchers identify key gene in deadly inflammatory breast cancerfrom PhysorgSun, 14 Jun 2009, 14:14:10 EDT
- NYU Langone Medical Center researchers identify key gene in deadly inflammatory breast cancerfrom Science BlogSun, 14 Jun 2009, 13:42:14 EDT
- Four New Targets For Breast Cancer Identifiedfrom Science DailyThu, 11 Jun 2009, 20:21:34 EDT
- Researchers identify four new targets for breast cancerfrom Science CentricThu, 11 Jun 2009, 6:08:09 EDT
- Researchers identify four new targets for breast cancerfrom Science BlogWed, 10 Jun 2009, 14:49:10 EDT
- Pathway Linked To Breast Cancer Stem Cellsfrom Science DailySun, 7 Jun 2009, 21:21:30 EDT
- Breast Cancer Gene Can Be Blocked By Blood Pressure Drugfrom Science DailySat, 6 Jun 2009, 23:35:26 EDT
- Researchers find breast cancer gene that's blocked by blood pressure drugfrom Science CentricThu, 4 Jun 2009, 1:49:25 EDT
- Targeting breast cancer stem cells in micefrom Science CentricWed, 3 Jun 2009, 21:56:05 EDT
- U-M researchers link pathway to breast cancer stem cellsfrom Science CentricWed, 3 Jun 2009, 21:21:13 EDT
- Targeting breast cancer stem cells in micefrom PhysorgTue, 2 Jun 2009, 7:21:17 EDT
- U-M researchers link pathway to breast cancer stem cellsfrom Science BlogMon, 1 Jun 2009, 20:35:06 EDT
- Researchers find breast cancer gene that's blocked by blood pressure drugfrom Science BlogMon, 1 Jun 2009, 18:42:19 EDT
- Researchers find breast cancer gene that's blocked by blood pressure drugfrom PhysorgMon, 1 Jun 2009, 17:49:15 EDT
- Biological Markers That May Indicate Poor Breast Cancer Prognosis Identifiedfrom Science DailySun, 31 May 2009, 0:28:29 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
No popular news yet
- From ocean to land: The fishy origins of our hips
- New method of finding planets scores its first discovery
- Invasive crazy ants are displacing fire ants in areas throughout southeastern US
- Seabird bones reveal changes in open-ocean food chain
- Scientific insurgents say 'Journal Impact Factors' distort science
No popular news yet
No popular news yet
- Stem cell transplant restores memory, learning in mice
- 2 landmark studies report on success of using image-guided brachytherapy to treat cervical cancer
- Researchers discover mushrooms can provide as much vitamin D as supplements
- Cutting back on sleep harms blood vessel function and breathing control
- Study: Low-dose aspirin stymies proliferation of 2 breast cancer lines